Literature DB >> 15738984

Testicular germ-cell tumours in a broader perspective.

J Wolter Oosterhuis1, Leendert H J Looijenga.   

Abstract

The germ-cell tumours are a fascinating group of neoplasms because of their unusual biology and the spectacular therapeutic results that have been obtained in these tumours. Traditionally, this group of neoplasms is presented in an organ-oriented approach. However, recent clinical and experimental data convincingly demonstrate that these neoplasms are one disease with separate entities that can manifest themselves in different anatomical sites. We propose five entities, in which the developmental potential is determined by the maturation stage and imprinting status of the originating germ cell. Recent progress begins to explain the apparent unpredictable development of germ-cell tumours and offers a basis for understanding their exquisite sensitivity to therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15738984     DOI: 10.1038/nrc1568

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  266 in total

1.  Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.

Authors:  Thomas Mueller; Lutz Peter Mueller; Hans-Juergen Holzhausen; Ralf Witthuhn; Peter Albers; Hans-Joachim Schmoll
Journal:  Histochem Cell Biol       Date:  2010-06-08       Impact factor: 4.304

Review 2.  Advances in the treatment of testicular cancer.

Authors:  Hans-Georg Kopp; Markus Kuczyk; Johannes Classen; Arnulf Stenzl; Lothar Kanz; Frank Mayer; Michael Bamberg; Jörg Thomas Hartmann
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Cancer/testis antigens and urological malignancies.

Authors:  Prakash Kulkarni; Takumi Shiraishi; Krithika Rajagopalan; Robert Kim; Steven M Mooney; Robert H Getzenberg
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

4.  Zebrafish models of germ cell tumor.

Authors:  Joanie C Neumann; Kate Lillard; Vanessa Damoulis; James F Amatruda
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

5.  Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.

Authors:  Rui Zhu; Yuan Ji; Lianchun Xiao; Angabin Matin
Journal:  Mamm Genome       Date:  2007-08-02       Impact factor: 2.957

6.  Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.

Authors:  Martin Blomberg Jensen; Anne Jørgensen; John Erik Nielsen; Andreas Steinmeyer; Henrik Leffers; Anders Juul; Ewa Rajpert-De Meyts
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 7.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

8.  The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.

Authors:  Anthony D Krentz; Mark W Murphy; Shinseog Kim; Matthew S Cook; Blanche Capel; Rui Zhu; Angabin Matin; Aaron L Sarver; Keith L Parker; Michael D Griswold; Leendert H J Looijenga; Vivian J Bardwell; David Zarkower
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

Review 9.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

10.  New perspective on molecular markers as promising therapeutic targets in germ cell tumors.

Authors:  Paolo Chieffi
Journal:  Intractable Rare Dis Res       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.